Effectiveness and Safety of Favipiravir Compared to Hydroxychloroquine for Management of Covid-19: A Retrospective Study

BACKGROUND: Coronavirus disease (COVID-19) is an infectious disease due to SARS-COV-2. Patients with risk factors are vulnerable to severe morbidity and mortality. Favipiravir (FPV) and hydroxychloroquine (HCQ) are considered possible COVID-19 treatments. OBJECTIVE: To investigate the effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Alotaibi, Musim, Ali, Ahmed, Bakhshwin, Duaa, Alatawi, Yasser, Alotaibi, Sultan, Alhifany, Abdullah, Alharthi, Badr, Alharthi, Nasser, Alyazidi, Awatef, Alharthi, Yasmeen, Alrafiah, Aziza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449635/
https://www.ncbi.nlm.nih.gov/pubmed/34548811
http://dx.doi.org/10.2147/IJGM.S329881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449635/
https://www.ncbi.nlm.nih.gov/pubmed/34548811
http://dx.doi.org/10.2147/IJGM.S329881

Ejemplares similares